前列腺癌患者根治性前列腺切除术前68Ga-HBEDD PSMA-11 PET/CT分期:对手术生化反应的诊断与预测价值
本研究分析142例根治性前列腺切除术前接受PSMA PET/CT分期的男性患者,评估其诊断与预测手术生化反应的价值。结果显示,PSMA PET发现前列腺外病变者手术反应率为28.6%(4/14),显著低于病变局限于前列腺者的82.9%(92/111)(p < 0.001);PSMA对手术反应的预测价值优于Gleason评分、PSA或pT分期。结论认为,术前PSMA PET发现前列腺外病变独立预测根治性前列腺切除术后手术反应差,可能提示需要多模式治疗。
要点
- 术前PSMA PET发现前列腺外病变者手术反应率28.6%,显著低于局限前列腺者的82.9%(p < 0.001)。
- PSMA PET对手术反应的预测价值优于Gleason评分、PSA或pT分期。
- MRI对精囊侵犯敏感度较低、特异度较高,对淋巴结受累敏感度较低。
核心结论
- 术前分期PSMA PET发现的前列腺外病变独立预测根治性前列腺切除术后手术反应差,可能提示需要多模式治疗。
研究设计与样本
- 研究分析了142例根治性前列腺切除术前接受分期PSMA PET/CT的男性患者。
- 收集数据包括PSMA PET/CT、骨扫描(30/142)、mpMRI(112/142)及根治性前列腺切除术后病理T分期、Gleason评分、手术切缘和淋巴结状态。
- 前列腺特异性抗原(PSA)在分期扫描时及手术后(中位45天,四分位距38-59天)记录,PSA < 0.03 ng/ml定义为手术反应(SR)。
- 采用逻辑回归分析术前临床变量与手术反应的关联。
关键影像表现/征象
- 97.9%(139/142)的男性PSMA显示前列腺内阳性发现。
- 14.1%(20/142)的男性PSMA PET发现额外的前列腺外病变部位。
- MRI对精囊侵犯的敏感度较低、特异度较高,对淋巴结受累的敏感度较低。
诊断标准与关键数值
- 手术反应定义为术后PSA < 0.03 ng/ml。
- 病变局限于前列腺的男性中82.9%(92/111)达到手术反应,而PSMA识别的前列腺外病变(淋巴结阳性和远处转移性疾病)男性中为28.6%(4/14)(p < 0.001)。
- 二元逻辑回归显示PSMA对手术反应的预测价值优于Gleason评分、PSA(成像时)或pT分期。
临床应用与阅片要点
- 术前PSMA PET分期发现前列腺外病变时,应记录淋巴结阳性和远处转移部位,因其与手术反应率降低相关。
- 报告PSMA PET时应描述前列腺内阳性发现及前列腺外病变部位,以辅助预测手术反应。
- 结合mpMRI时,注意MRI对精囊侵犯敏感度较低、特异度较高,对淋巴结受累敏感度较低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
METHODS:: We analysed results of 142 males with staging PSMA prior to radical prostatectomy (RP). Data collected included PSMA PET/CT, bone scan (30/142), mpMRI (112/142), and pathological T stage (pT) stage, Gleason score, surgical margins and lymph node status at RP. Prostate-specific antigen (PSA) was documented at staging scan, and following surgery (median 45 days (interquartile range 38-59). A PSA of < 0.03 ng ml-1 was classified as surgical response (SR). Logistic regression was performed for association of pre-operative clinical variables and SR.
RESULTS:: 97.9% (139/142) of males had positive intraprostatic findings on PSMA. 14.1 % (20/142) of males had further sites of extra prostatic disease identified on PSMA PET. In males with disease confined to the prostate, 82.9 % (92/111) achieved an SR, compared to 28.6 % (4/14) in males with extraprostatic disease identified (lymph node positive and distant metastatic disease) (p < 0.001). On binary logistic regression PSMA had a superior predictive value for SR than Gleason score, PSA (at time of imaging) or pT stage. MRI was less sensitive and more specific for SVI, and less sensitive for nodal involvement.
CONCLUSION:: Extraprostatic disease identified on staging pre-operative PSMA PET is independently predictive of a poor surgical response to RP, and may indicate a need for a multimodality approach to treatment.
ADVANCES IN KNOWLEDGE:: This is one of the first studies to correlate the PSMA PET's staging capacity to prostate cancer patient's outcomes to radical prostatectomy and indicates it's potential in predicting which patients will benefit from radical prostatectomy.
引用
- Nandurkar R, van Leeuwen P, Stricker P, et al. 68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery. Br J Radiol. 2019. PMID: 30563350. doi:10.1259/bjr.20180667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。